1-5 of 5
Ioanna Tsakos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma

Clinical Trials & Observations
Nikoletta Lendvai, Andrew J. Yee, Ioanna Tsakos, Aeri Alexander, Sean M. Devlin, Hani Hassoun, Neha Korde, Alexander M. Lesokhin, Heather Landau, Sham Mailankody, Guenther Koehne, David J. Chung, Ola Landgren, Noopur S. Raje, Sergio Giralt
Journal: Blood
Blood (2016) 127 (19): 2355–2356.
https://doi.org/10.1182/blood-2016-01-694786
Published: 2016
Journal Articles

Recombinant (rec) MAGE-A3 Protein Immunotherapy and Peripheral Blood Lymphocyte (PBL) Reconstitution Induce Strong Antigen-Specific Humoral and Cellular Immune Responses in Patients Undergoing Autologous Stem Cell Transplantation (ASCT) for Consolidation of Multiple Myeloma (MM)

Adam D. Cohen, MD, Nikoletta Lendvai, MDPhD, Sacha Gnjatic, PhD, Achim A Jungbluth, MD, Stephane Bertolini, Linda Pan, Pharm.D., Ralph Venhaus, Ioanna Tsakos, Katarzyna Garcia, MS, Linda Thibodeau, RN, Katherine Alpaugh, PhD, Nailah Cummings, Rafik Fellague-Chebra, MD, Olivier Gruselle, Hearn J. Cho, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1184.
https://doi.org/10.1182/blood.V124.21.1184.1184
Published: 2014
Journal Articles

A phase 2 single-center study of carfilzomib 56 mg/m 2 with or without low-dose dexamethasone in relapsed multiple myeloma

Clinical Trials & Observations
Nikoletta Lendvai, Patrick Hilden, Sean Devlin, Heather Landau, Hani Hassoun, Alexander M. Lesokhin, Ioanna Tsakos, Kaitlyn Redling, Guenther Koehne, David J. Chung, Wendy L. Schaffer, Sergio A. Giralt
Journal: Blood
Blood (2014) 124 (6): 899–906.
https://doi.org/10.1182/blood-2014-02-556308
Published: 2014
Includes: Supplemental data
Journal Articles

MAGE-A3 Recombinant Protein (recMAGE-A3) Immunotherapy and Autologous Peripheral Blood Lymphocyte (PBL) Infusion Is Safe and Induces Robust Humoral Immune Responses In Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplantation (autoSCT)

Adam D Cohen, MD, Nikoletta Lendvai, MD PhD, Sacha Gnjatic, Ph.D., Achim A Jungbluth, MD, Stephane Bertolini, Linda Pan, Pharm.D., Ralph Venhaus, Ioanna Tsakos, Katarzyna Garcia, MS, Linda Thibodeau, RN, Katherine Alpaugh, PhD, Nailah Cummings, Rafik Fellague-Chebra, MD, Olivier Gruselle, Hearn J. Cho, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 154.
https://doi.org/10.1182/blood.V122.21.154.154
Published: 2013
Journal Articles

Phase II Study of Infusional Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma

Nikoletta Lendvai, MD PhD, Heather Landau, MD, Alexander Lesokhin, MD, Ioanna Tsakos, BS, Guenther Koehne, MD, PhD, David Chung, MD PhD, Sean Devlin, PhD, Hani Hassoun, MD, Sergio A Giralt, MD
Journal: Blood
Blood (2012) 120 (21): 947.
https://doi.org/10.1182/blood.V120.21.947.947
Published: 2012